Factors involved in the loss of bone mineral density after renal transplantation.
Torregrosa
J V
JV
Renal Transplant Unit, Hospital Clinic, University of Barcelona, Spain.
Campistol
J M
JM
Montesinos
M
M
Fenollosa
B
B
Pons
F
F
Martinez de Osaba
M J
MJ
Oppenheimer
F
F
D000328:Adult; D000368:Aged; D000535:Aluminum / Q000097:blood; D015519:Bone Density; D002117:Calcitriol / Q000097:blood; D002118:Calcium / Q000097:blood; D016009:Chi-Square Distribution; D003404:Creatinine / Q000097:blood; D016572:Cyclosporine / Q000627:therapeutic use; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D006961:Hyperparathyroidism / Q000150:complications / Q000503:physiopathology; D007165:Immunosuppression Therapy / Q000379:methods*; D016030:Kidney Transplantation / Q000502:physiology*; D008297:Male; D008775:Methylprednisolone / Q000627:therapeutic use; D008875:Middle Aged; D010710:Phosphates / Q000097:blood; D011241:Prednisone / Q000627:therapeutic use; D012016:Reference Values; D012044:Regression Analysis; D013997:Time Factors
D010710:Phosphates; D016572:Cyclosporine; D003404:Creatinine; D000535:Aluminum; D002117:Calcitriol; D002118:Calcium; D011241:Prednisone; D008775:Methylprednisolone